Acute respiratory distress syndrome: Current concepts and future directions

Anaesthesia and Intensive Care

Volumn 41, Issue 4, 2013, Pages 463-472

  Frohlich S ^a   Murphy, N ^a   Ryan, D ^a   Boylan, J F ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

ALI; Ards; Future; Treatment

Indexed keywords

ACETYLCYSTEINE; ADENOSINE RECEPTOR STIMULATING AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA1A INTERFERON; BIOLOGICAL PRODUCT; CISATRACURIUM; DROTRECOGIN; FP 1201; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOMODULATING AGENT; LISOFYLLINE; NEUROMUSCULAR BLOCKING AGENT; NITRIC OXIDE; PLACEBO; PROSTACYCLIN; PROSTAGLANDIN E1; ROSUVASTATIN; SIMVASTATIN; STEROID; SURFACTANT; UNCLASSIFIED DRUG; VASODILATOR AGENT;

2009 H1N1 INFLUENZA; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; AUSTRALIA; BODY POSTURE; CRITICALLY ILL PATIENT; DEATH; DRUG MECHANISM; EXTRACORPOREAL OXYGENATION; HIGH FREQUENCY OSCILLATION; HIGH FREQUENCY VENTILATION; HUMAN; MESENCHYMAL STEM CELL; MORTALITY; NONHUMAN; RESPIRATORY DISTRESS SYNDROME; REVIEW; TREATMENT FAILURE; TREATMENT PLANNING; ALI; FUTUROLOGY; METHODOLOGY; PATHOPHYSIOLOGY; TREATMENT;

ALI; ARDS; FUTURE; TREATMENT;

EXTRACORPOREAL MEMBRANE OXYGENATION; HIGH-FREQUENCY VENTILATION; HUMANS; POSTURE; PRONE POSITION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; VASODILATOR AGENTS;

MLCS; MLOWN;

EID: 84881255570     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1304100405     Document Type: Review

References (80)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310.
3. Sheu CC, Gong MN, Zhai R, Chen F, Bajwa EK, Clardy PF et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest 2010; 138:559-567.
4. Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management. Crit Care 2008; 12:R30.
5. Angus DC, Musthafa AA, Clermont G, Griffin MF, Linde-Zwirble WT, Dremsizov TT et al. Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163:1389-1394.
6. Rubenfeld GD. Epidemiology of acute lung injury. Crit Care Med 2003; 31:S276-284.
7. Schelling G, Stoll C, Vogelmeier C, Hummel T, Behr J, Kapfhammer HP et al. Pulmonary function and health-related quality of life in a sample of long-term survivors of the acute respiratory distress syndrome. Intensive Care Med 2000; 26:1304-1311.
8. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009; 302:1888-1895.
9. Phua J, Badia JR, Adhikari NKJ, Friedrich JO, Fowler RA, Singh JM et al. Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med 2009; 179:220-227.
10. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network.
11. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347-354.
12. Villar J, Kacmarek RM, Perez-Mendez L, Aguirre-Jaime A. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006; 34:1311-1318.
13. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012; 122:2731-2740.
14. Bower R. Effects of tidal volume reduction in acute lung injury (ALI) patients with inspiratory plateau pressures < 32 cmH2O before tidal volume reduction. Am J Respir Crit Care Med 2003; 167:A616.
15. Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med 2007; 175:160-166.
16. Hager DN, Krishnan JA, Hayden DL, Brower RG. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 2005; 172:1241-1245.
17. Bein T, Weber-Carstens S, Goldmann A, Muller T, Staudinger T, Brederlau J et al. Lower tidal volume strategy (approximately 3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS : The prospective randomized Xtravent-study. Intensive Care Med 2013; 39:847-856.
18. McMullen SM, Meade M, Rose L, Burns K, Mehta S, Doyle R et al. Partial ventilatory support modalities in acute lung injury and acute respiratory distress syndrome-a systematic review. PLoS One 2012; 7:e40190.
19. Falke KJ, Pontoppidan H, Kumar A, Leith DE, Geffin B, Laver MB. Ventilation with end-expiratory pressure in acute lung disease. J Clin Invest 1972; 51:2315-2323.
20. Webb HH, Tierney DF. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures. Protection by positive end-expiratory pressure. Am Rev Respir Dis 1974; 110:556-565.
21. Dasenbrook EC, Needham DM, Brower RG, Fan E. Higher PEEP in patients with acute lung injury: a systematic review and meta-analysis. Respir Care 2011; 56:568-575.
22. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010; 303:865-873.
23. Putensen C, Theuerkauf N, Zinserling J, Wrigge H, Pelosi P. Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med 2009; 151:566-576.
24. Grasso S, Fanelli V, Cafarelli A, Anaclerio R, Amabile M, Ancona G. Effects of high versus low positive end-expiratory pressures in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005; 171:1002-1008.
25. Hodgson CL, Tuxen DV, Davies AR, Bailey MJ, Higgins AM, Holland AE et al. A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome. Crit Care 2011; 15:R133.
26. Tugrul S, Akinci O, Ozcan PE, Ince S, Esen F, Telci L et al. Effects of sustained inflation and postinflation positive endexpiratory pressure in acute respiratory distress syndrome: focusing on pulmonary and extrapulmonary forms. Crit Care Med 2003; 31:738-744.
27. Borges JB, Okamoto VN, Matos GFJ, Caramez MPR, Arantes PR, Barros F et al. Reversibility of lung collapse and hypoxemia in early acute respiratory distress syndrome. Am J Respir Crit Care Med 2006; 174:268-278.
28. Brower RG, Morris A, MacIntyre N, Matthay MA, Hayden D, Thompson T et al. Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure. Crit Care Med 2003; 31:2592-2597.
29. Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354:1775-1786.
30. Kacmarek RM, Villar J. Lung recruitment maneuvers during acute respiratory distress syndrome: is it useful? Minerva Anestesiol 2011; 77:85-89.
31. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575.
32. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005; 33:1681-1687.
33. Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002; 30:2175-2182.
34. Taccone P, Pesenti A, Latini R, Polli F, Vagginelli F, Mietto C et al. Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial. JAMA 2009; 302:1977-1984.
35. Charron C, Bouferrache K, Caille V, Castro S, Aegerter P, Page B et al. Routine prone positioning in patients with severe ARDS: feasibility and impact on prognosis. Intensive Care Med 2011; 37:785-790.
36. Y oung D, Lamb SE, Shah S, MacKenzie I, Tunnicliffe W, Lall R et al. High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 2013; 368:806-813.
37. Ferguson ND, Cook DJ, Guyatt GH, Mehta S, Hand L, Austin P et al. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013; 368:795-805.
38. Malhotra A, Drazen JM. High-frequency oscillatory ventilation on shaky ground. N Engl J Med 2013; 368:863-865.
39. Afshari A, Brok J, Moller AM, Wetterslev J. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev 2010; n/a:CD002787.
40. Michael JR, Barton RG, Saffle JR, Mone M, Markewitz BA, Hillier K et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998; 157:1372-1380.
41. L undin S, Mang H, Smithies M, Stenqvist O, Frostell C. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999; 25:911-919.
42. Gerlach H, Keh D, Semmerow A, Busch T, Lewandowski K, Pappert DM et al. Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med 2003; 167:1008-1015.
43. L owson SM. Inhaled alternatives to nitric oxide. Crit Care Med 2005; 33:S188-195.
44. Siobal M. Aerosolized prostacyclins. Respir Care 2004; 49:640-652.
45. Raoof S, Goulet K, Esan A, Hess DR, Sessler CN. Severe hypoxemic respiratory failure: part 2-nonventilatory strategies. Chest 2010; 137:1437-1448.
46. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979; 242:2193-2196.
47. Morris AH, Wallace CJ, Menlove RL, Clemmer TP, Orme JF Jr, Weaver LK et al. Randomized clinical trial of pressurecontrolled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 149:295-305.
48. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374:1351-1363.
49. Johnson P, Frohlich S, Westbrook A. Use of extracorporeal membrane lung assist device (Novalung) in H1N1 patients. J Card Surg 2011; 26:449-452.
50. Batchinsky AI, Jordan BS, Regn D, Necsoiu C, Federspiel MJ, Morris MJ et al. Respiratory dialysis: reduction in dependence on mechanical ventilation by venovenous extracorporeal CO2 removal. Crit Care Med 2011; 39:1382-1387.
51. Adhikari N, Burns KEA, Meade MO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2004; n/a:CD004477.
52. Forel JM, Roch A, Marin V, Michelet P, Demory D, Blache JL, Perrin G et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006; 34:2749-2757.
53. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354:1671-1684.
54. Brun-Buisson C, Richard JCM, Mercat A, Thiebaut ACM, Brochard L. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011; 183:1200-1206.
55. Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ et al. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 2011; 183:1207-1214.
56. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007; 131:954-963.
57. Tang BMP, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009; 37:1594-1603.
58. Stapleton RD, Wang BM, Hudson LD, Rubenfeld GD, Caldwell ES, Steinberg KP. Causes and timing of death in patients with ARDS. Chest 2005; 128:525-532.
59. Ferguson ND, Frutos-Vivar F, Esteban A, Fernandez-Segoviano P, Aramburu JA, Najera L et al. Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med 2005; 33:2228-2234.
60. Bersten AD, Edibam C, Hunt T, Moran J. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. Am J Respir Crit Care Med 2002; 165:443-448.
61. Villar J, Blanco J, Anon JM, Santos-Bouza A, Blanch L, Ambros A et al. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med 2011; 37:1932-1941.
62. Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009; 37:1574-1579.
63. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012; 38:1573-1582.
64. Frohlich S, Murphy N, Boylan J. Definition of acute respiratory distress syndrome. JAMA 2012; 308:1321-1322; author re.
65. Cross LJM, Matthay MA. Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury. Crit Care Clin 2011; 27:355-377.
66. O pitz B, van Laak V, Eitel J, Suttorp N. Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med 2010; 181:1294-1309.
67. Goldenberg NM, Steinberg BE, Slutsky AS, Lee WL. Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med 2011; 3:88ps25.
68. Chapman HA, Li X, Alexander JP, Brumwell A, Lorizio W, Tan K et al. Integrin alpha6beta4 identifies an adult distal lung epithelial population with regenerative potential in mice. J Clin Invest 2011; 121:2855-2862.
69. Kor DJ, Iscimen R, Yilmaz M, Brown MJ, Brown DR, Gajic O. Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury. Intensive Care Med 2009; 35:1039-1046.
70. Heller AR, Rothermel J, Weigand MA, Plaschke K, Schmeck J, Wendel M et al. Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung. Eur J Anaesthesiol 2007; 24:258-266.
71. Kiss J, Yegutkin GG, Koskinen K, Savunen T, Jalkanen S, Salmi M. IFN-beta protects from vascular leakage via up-regulation of CD73. Eur J Immunol 2007; 37:3334-3338.
72. Faron Pharmaceuticals. From http://www.faronpharmaceuticals. com/news. Accessed March 2012.
73. Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH et al. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 2007; 354:700-706.
74. Nemeth K, Leelahavanichkul A, Yuen PST, Mayer B, Parmelee A, Doi K et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15:42-49.
75. L i TS, Hayashi M, Ito H, Furutani A, Murata T, Matsuzaki M et al. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-betapreprogrammed bone marrow stem cells. Circulation 2005; 111:2438-2445.
76. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005; 289:F31-42.
77. McCarter SD, Mei SHJ, Lai PFH, Zhang QW, Parker CH, Suen RS et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 2007; 175:1014-1026.
78. Mutlu GM, Machado-Aranda D, Norton JE, Bellmeyer A, Urich D, Zhou R et al. Electroporation-mediated gene transfer of the Na+,K+ -ATPase rescues endotoxin-induced lung injury. Am J Respir Crit Care Med 2007; 176:582-590.
79. Kabay B, Teke Z, Aytekin FO, Yenisey C, Bir F, Sacar M et al. Pyrrolidine dithiocarbamate reduces lung injury caused by mesenteric ischemia/reperfusion in a rat model. World J Surg 2007; 31:1707-1715.
80. Frohlich S, Boylan J, McLoughlin P. Hypoxia-induced inflammation in the lung: a potential therapeutic target in acute lung injury? Am J Respir Cell Mol Biol 2013; 48:271-279.